Back to Quality Research
HNNAHennessy Ad
Unknown
$10.18−0.20%
As of 23 Oct 2026Mkt cap —
Stage 13
WATCH
Fundamentals
55.6/75
Technical
11.2/15
Independent
66.9/90
GCAE viewbusiness is credible but technical recovery is not yet actionable
Price
- 1M
- −0.1%
- 3M
- +3.4%
- 6M
- +3.2%
- 1Y
- +13.5%
Financials & valuation
Capital Markets specialist profile · Frozen specialist production evidence
Valuation
- Specialist lens
- Book-value / earnings valuation
Quality
- Specialist lens
- ROE, ROA, margins, earnings stability and equity strength
Growth
- Specialist lens
- Income, EPS, revenue and equity growth
Capital / risk
- Specialist lens
- Equity-to-assets and share-count discipline
- Fundamental evidence
- 55.6 /75 frozen production score
- Evidence state
- fresh
GCAE Research
- Quality Research
- PRE-AI
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- DROPPED · CURRENT
Key takeaway
Cheap, but weak compounding profile and AUM sensitivity dominate.
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
More details & evidence
Production decision
- Stage 13
- WATCH
- Technical state
- approaching-support
- Rotation
- unknown
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- Unavailable
- Quality Research
- CURRENT
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded